The treatments with statins and zoledronic acid also significantly reduced the expression of the anti-apoptotic genes Bcl-2 and Svv, even in chemo-resistant A2780cis cells, which is in line with studies in breast, colorectal, and prostate cancer [84–87]. Here, BCL2 is linked to prostate carcinoma.